Publications by authors named "Mate Deri"

Claim this Profile
C
CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients.
Máté Déri, Zsófia Szakál-Tóth, Ferenc Fekete, Katalin Mangó, Evelyn Incze

Sci Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of genetic and non-genetic factors on hepatic CYP2C9 expression and activity in Hungarian subjects.
Ferenc Fekete, Katalin Mangó, Máté Déri, Evelyn Incze, Annamária Minus

Sci Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of personalized tacrolimus dosing by adjusting to donor CYP3A-status in liver transplant recipients.
Nóra Csikány, Ádám Kiss, Máté Déri, Ferenc Fekete, Annamária Minus

Br J Clin Pharmacol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Inhibitory and Absorption, Distribution, Metabolism, Excretion, and Toxicology (ADMET) Properties of Blebbistatin Derivatives Indicate That Blebbistatin Scaffold Is Ideal for drug Development Targeting Myosin-2.
Máté Gyimesi, Anna Á Rauscher, Sharad Kumar Suthar, Kamirán Á Hamow, Kinga Oravecz

J Pharmacol Exp Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450s.
Máté Tamás Déri, Ádám Ferenc Kiss, Katalin Tóth, József Paulik, Enikő Sárváry

Pharmacol Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia.
Ádám Menus, Ádám Kiss, Katalin Tóth, Dávid Sirok, Máté Déri

Sci Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure.
Ádám Kiss, Ádám Menus, Katalin Tóth, Máté Déri, Dávid Sirok

Eur Arch Psychiatry Clin Neurosci· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isoform-Dependent Changes in Cytochrome P450-Mediated Drug Metabolism after Portal Vein Ligation in the Rat.
Tibor Kovács, Máté Déri, András Fülöp, Tímea Pálházy, Edit Háfra

Eur Surg Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of CYP2C9 Function in Valproate Therapy.
Katalin Monostory, Andrea Nagy, Katalin Tóth, Tamás Bűdi, Ádám Kiss

Curr Neuropharmacol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of CYP2C19 genotype with non-genetic factors evoking phenoconversion improves phenotype prediction.
Ádám Ferenc Kiss, Dorottya Vaskó, Máté Tamás Déri, Katalin Tóth, Katalin Monostory

Pharmacol Rep· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics.
Katalin Tóth, Gábor Csukly, Dávid Sirok, Ales Belic, Ádám Kiss

Int J Neuropsychopharmacol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.
Katalin Tóth, Gábor Csukly, Dávid Sirok, Ales Belic, Ádám Kiss

Int J Neuropsychopharmacol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis